Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AGT May Serve as a Prognostic Biomarker and Correlated with Immune Infiltration in Gastric Cancer. | Int J Gen Med | 2022 | 35264871 | PubTator, text mining | PubMed |
| LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. | Hereditas | 2022 | 35241179 | PubTator, text mining | PubMed |
| Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma. | Cell Rep | 2022 | 35235789 | PubTator, text mining | PubMed |
| A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates. | J Clin Transl Hepatol | 2022 | 35233377 | PubTator, text mining | PubMed |
| The next wave of cellular immunotherapies in pancreatic cancer. | Mol Ther Oncolytics | 2022 | 35229033 | PubTator, text mining | PubMed |
| A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of ALKBH7. | Front Genet | 2022 | 35222541 | PubTator, text mining | PubMed |
| SCNN1A Overexpression Correlates with Poor Prognosis and Immune Infiltrates in Ovarian Cancer. | Int J Gen Med | 2022 | 35221714 | PubTator, text mining | PubMed |
| High expression of the ferroptosis-associated MGST1 gene in relation to poor outcome and maladjusted immune cell infiltration in uterine corpus endometrial carcinoma. | J Clin Lab Anal | 2022 | 35218676 | PubTator, text mining | PubMed |
| Lymphatics in Tumor Progression and Immunomodulation. | Int J Mol Sci | 2022 | 35216243 | PubTator, text mining | PubMed |
| Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment. | Front Immunol | 2022 | 35211124 | PubTator, text mining | PubMed |
| Chemokine (C-C Motif) Ligand 8 and Tubulo-Interstitial Injury in Chronic Kidney Disease. | Cells | 2022 | 35203308 | PubTator, text mining | PubMed |
| CCR8 is a new therapeutic target in cutaneous T-cell lymphomas. | Blood Adv | 2022 | 35201316 | PubTator, text mining | PubMed |
| Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV. | JCI Insight | 2022 | 35192543 | PubTator, text mining | PubMed |
| Overexpression of CAPG Is Associated with Poor Prognosis and Immunosuppressive Cell Infiltration in Ovarian Cancer. | Dis Markers | 2022 | 35186171 | PubTator, text mining | PubMed |
| Overexpressed CMTM6 Improves Prognosis and Associated With Immune Infiltrates of Ovarian Cancer. | Front Mol Biosci | 2022 | 35174213 | PubTator, text mining | PubMed |
| MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma. | Front Oncol | 2022 | 35174083 | PubTator, text mining | PubMed |
| The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy. | Cancers (Basel) | 2022 | 35159113 | PubTator, text mining | PubMed |
| Chemokine Receptor-Targeted Therapies: Special Case for CCR8. | Cancers (Basel) | 2022 | 35158783 | PubTator, text mining | PubMed |
| Functional and molecular characterization of PD1+ tumor-infiltrating lymphocytes from lung cancer patients. | Oncoimmunology | 2022 | 35154905 | PubTator, text mining | PubMed |
| Role of Thymus and Activation-Regulated Chemokine in Allergic Asthma. | J Asthma Allergy | 2022 | 35153491 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=37